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REVIEW of the cancer deaths among 1202 staged cases of carcinoma of the cervix 
treated at the Radiation Therapy Center of the University of Michigan from 1941 
through 1964 indicates that each clinical stage is endowed with its own singular 
mortality trend. The cancer mortality trend of each stage is in our experience inde- 
pendent of the 5-yr survival rate. Improved survival obtained through the use of 
more effective therapeutic methods has not altered the mortality trend of each stage. 
We have also obtained evidence that when the logarithm of survival time of the 
patients destined to die of cancer is plotted against time the line of regression is 
straight. These observations are based on examination of the following case material. 
CASE MATERIAL 
This report includes all patients who began treatment for carcinoma of the cervix 
uteri at the Radiation Therapy Center of the University of Michigan between January 
1941 and December 1964. Some stage IV cases did not conclude the prescribed treat- 
ment because of the deterioration that such advanced degree of disease produces. 
A few other patients died during treatment due to intercurrent disease. Among the 
1202 cases that constitute the basis of this report there are both squamous cell and 
adenocarcinomas but all unclassified and previously treated cases have been excluded. 
All patients have been observed for at least 5 yr after treatment or for as long as they 
have lived and we have information regarding the fate of all cases. 
STAGING 
Carcinoma of the cervix uteri is staged in our institution according to the Inter- 
national Classification [l]. The act of staging is carried out in a joint Conference of 
the Department of Gynecology and the Radiation Therapy Center. The patients are 
examined by at least two, very often three, senior members of those departments and 
staged by agreement. 
*Reprint Address: Radiation Therapy Center, University Hospital, Ann Arbor, Michigan 
48104, U.S.A. 
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DEFINITIONS 
This paper is concerned with the cancer mortality trend of the stages I-IV of 
carcinoma of the cervix uteri. By mortality trend we mean the successive accumulation 
of deaths, specifically cancer deaths, during the first five years after treatment. By 
cancer death we mean the demise of a patient in whom cancer of the cervix was present. 
By intercurrent death we mean that at the time of death a former patient of carcinoma 
of the cervix was not known to harbor that tumor. The relative youth of most patients 
with carcinoma of the cervix uteri prevents the accumulation of many deaths due to 
intercurrent disease. 
TREATMENT 
Primary treatment of carcinoma of the cervix is intracavitary radium application 
but a very important adjunct to it is external irradiation. Most of our patients have 
been treated with a combination of both. The intensity of radium therapy began to 
increase at the end of the 1941-1950 decade. This intensification of the treatment was 
gradual so that no date can be chosen that separates in this respect one treatment 
period from another. External irradiation, on the contrary, changed abruptly when 
Cobalt 60 radiation became available in 1956. The tumor dose that can be delivered 
with this type of radiation is much higher than with the previously employed deep 
X-ray therapy and the complications are fewer. The combination of higher intensity 
radium treatment and improved external irradiation is clearly marked in our experi- 
ence by more favorable 5-yr survival rates. Our material can thereby be divided into 
two groups: (a) patients treated between 1941 through 1955 and (b) patients treated 
between 1956 and 1964. 
CUMULATIVE MORTALITY 
The distribution of cases by stage and treatment period is shown in Table 1. It 
also indicates the overall crude 5-yr survival rate and for two treatment periods. The 
distribution of cases by age groups for the periods with different survival rates is very 
similar. Stage III patients have a tendency to be slightly older and this difference 
has been more marked during the period 1956-1964. 
TABLE 1. DWRIB~ION OF CASES BY STAGE AND PERIOD 
Stage I II III IV 
1941-1955 232 350 256 53 
1956-1964 116 106 83 6 
Total 348 456 339 59 
Overall crude 5-yr survival rate and for two treatment periods 
Stage I II III IV 
1941-1955 69.8% 57.1% 22.6% 7.5% 
1956-1964 77.5% 68.8% 43.3% 16.6% 
1941-1964 72.4% 59.8% 27.7% 8.5% 
x* value for difference in survival between periods 25.82 P < 0.001 
The data on cumulative cancer mortality from carcinoma of the cervix uteri are 
presented in Tables 2-4 and displayed in Fig. 1 for the whole period of interest and 
for the two periods for which we have found different 5-yr survival rates. We do not 
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present a comparative table for stage IV because the number of patients during the 
period 1956-1964 is very small. Among our cases 75 per cent of all cancer deaths 
from stage IV occur during the first post-treatment year and by the third post-treat- 
ment year all patients that are to die of the disease during the first 60 post-treatment 
months will have done so. 
TABLE 2. CUMULATIVE MORTALITY-STAGE I 
All cases 1941-1955 1956-1964 
No. of No. of No. of 
Yr deaths Fraction deaths Fraction deaths Fraction 
1 12 0.151 8 0.134 4 0.222 
2 35 0.443 26 0.426 9 0.500 
3 59 0.746 46 0.754 13 0.722 
4 71 0.898 55 0.901 16 0.888 
5 79 1.000 61 1.000 18 l.ooO 
TABLE 3. CUMULATWE MORTALITY-STAGE II 
All cases 
No. of 
Yr deaths Fraction 
1 50 0.287 
2 105 0.603 
: 136 6 0.787 954
5 174 1.000 
1941- -1955 19561964 
No. of No. of 
deaths Fraction deaths Fraction 
41 0.286 9 0.290 
86 0.607 19 0.612 
110 0.769 26 0.838 
137 0.976 29 0.935 
143 1.000 31 1.000 
TABLE 4. CUMULATIVE MORTALITY-STAGE 111 
All cases 
No. of 
Yr deaths Fraction 
1 107 0.449 
2 174 0.731 
3 207 0.869 
4 225 0.945 
5 238 1.000 
1941-1955 1956-1964 
No. of No. of 
deaths Fraction deaths Fraction 
89 0.458 18 0.409 
144 0.742 30 0.681 
167 0.860 40 0.909 
181 0.932 44 1.000 
194 1.000 44 1.000 
Stage 2I 
Y’ Yr Y' 
FIG. 1. Display of the data of Tables 2-4. The regression line has heen fitted through 
parabolic equations. 
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The parallelism of the mortality trends between periods with different 5-yr survival 
rates indicates that the form of the mortality trend is strongly related to the stage of 
the disease. 
REVIEW OF THE MEDICAL LITERATURE 
Our finding that each stage of carcinoma of the cervix uteri is endowed with its 
own mortality trend is supported by review of the medical literature. We have tabu- 
lated mortality data from several sources and we have divided them into two groups. 
Table 5 presents the cumulative cancer mortality from two institutions that report 
results of treatment in the period 1922-1934 [2, 31. Table 6 presents cumulative cancer 
mortality from various sources [2, 4-61 among cases treated between 1932 and 1954 
and compares them with our own results. The tables have been assembled from 
explicit information offered by the authors except in the case of Manchester [4] whose 
data have been read out of graphs adjusted for age. The first-year mortality in stage III 
from Manchester is distinctly out of step with the rest. However, from the second year 
on, the mortality trend is in line with the data from the other institutions. 
TABLE 5. CUMULATIVE CANCER MORTALITY FROM TWOCENTERS REPORTING RADIUM THERAPY ONLY. 
YR 1922-1934 







No. of cancer deaths 
5-yr survival 
*Crude 
Stage I Stage II Stage III 
(2) (3) (2) (3) (2) (3) 
164 47 596 185 614 418 
0.250 0.400 0.312 0.293 
0.550 0.650 0.681 0.655 
0.750 0.700 0.862 0.818 
0.950 0.750 0.928 0.922 
1.000 1 .oOO 1.000 1.000 
60 20 349 116 





1 .oOO 1.000 
484 340 
17.8%* 18.70/6* 
We have omitted the data for stage I from Sheffield because the number of deaths 
was small. 
In Table 7 we have pooled all the data from Table 6, added stage IV data and 
obtained general mortality trends. 
Slight variations are present in the mortality trends as reported from various 
sources. However the differences between stages are so great that they overshadow 
the disparities within a stage among several institutions. The steadiness of stage II is 
notable. In stage III we find the discordant note of the first year mortality from 
Manchester. This displacement towards earlier death was not kept after the second 
year for the mortality for the second, third, fourth and fifth years is concordant with 
the rest. 
The group of cases in stage I reported by Sorensen (Table 5, second column) 
behaves in a manner very different from that of all other sources. When the survival 
of this group of cases is plotted on logarithmic probabilistic paper as Boag suggested 
[7] it does not follow a straight line. 
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TABLE 6. MORTALITY TRENDS, BY STAGE,FROM VARIOUSSOURCES. YR 1932-1964 







No. of cancer deaths 
S-yr survival rate 







No. of cancer deaths 
5-yr survival rate 







No. of cancer deaths 













0.291 0.259 0.291 0.333 0.287 
0.645 0.659 0.604 0.661 0.603 
0.791 0.798 0.791 0.848 0.787 
0.937 0.954 0.895 0.948 0.954 
1.000 1.000 1.000 1.000 1.000 
869 101 97 639 174 
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TABLE 7. CUMULATIVE 5-YR CANCER MORTALITY. GENERAL COMPUTATION 
Stage I II III IV 
No. of cases 978 4075 2916 1262 
Fraction dead 
1st yr 0.168 0.303 0.545 0.758 
2nd yr 0.511 0.645 0.776 0.904 
3rd yr 0.759 0.810 0.894 0.975 
4th yr 0.913 0.938 0.954 0.989 
5th yr 1.000 1.000 1.000 1.000 
No. of cancer deaths 244 1880 1995 1125 
THE EXPONENTIAL FUNCTION 
Inspection of the trend of cumulative death in stage III cases (Fig. 1) shows that 
approximately one half of the deaths that are to occur during the first five post- 
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treatment years have occurred during the first year after treatment. Half as many 
occur during the second. This suggests that the process of attrition of the population 
destined to die of cancer may be exponential. We have plotted the logarithm of 
duration of survival for patients that have died of cancer against time in Figs. 2 and 3. 
For stage I (76 deaths) and stage II (160 deaths) the computation has been restricted 
to data from the period 1941-1959, for these stages show a sizable mortality after the 
60th post treatment month and 10 yr follow-up is mandatory. For stages III and IV 
we have used only 5-yr follow-up data. Among all the stage III patients treated between 
1941 and 1959 only 5 cancer deaths have occurred between the 60th and 120th months. 
In stage IV we have no instance of cancer death between the 3rd and 10th yr. 
The survival has been plotted by bimesters and as having been registered midway 
in the 2 month period except for the deaths occurring after 5 yr. The latter have 
been plotted whenever they took place. 
The resemblance of these curves to those of cell survival after irradiation is uncanny. 
It will be noted that the straight portion of the regression line does not cross the 
ordinate at level 1.00 in stages I-III. The displacement of the straight segment of 
the curves towards the right is present in systems in which, it is postulated, there is 
a redundancy of targets where death occurs, according to this view, when several 
targets are neutralized either simultaneously or consecutively. When the neutralization 
of a single target is enough to cause death the exponential regression line crosses the 
ordinate at level 1.00 [8]. The displacement of the straight segment towards the right 
indicates a multiplicity of targets. An index of this multiplicity is the extrapolation 
number. The latter is obtained by extrapolating back the straight segment of the 
curve and reading the value of its intersection with the ordinate. 
Because of the displacement of the regression line towards the right a simple 
exponential would not fit the data for stages I-III. The equation 
S=l-(1-e-k’) 
does. S is the proportion of doomed survivors alive at a given time t, e is the base of 
natural logarithms and k is a constant identical in function with a decay constant. 
Note that the expression (l-eekt) indicating the proportion of patients dead at 
time t is raised to a power n (the extrapolation number), in order to take into account 
the displacement of the curve towards the right. 
The curves of Figs. 2 and 3 have been fitted by sight. The constant k has the 
dimensions months-‘. It has been obtained by dividing 0.693 by the half lethality 
period, the latter being read out directly from the graphs. 
The information available regarding the trend of mortality during the first post- 
treatment year is scanty. We have compared our data with Sorensen’s [3] and the fit 
is extremely close for stages II-IV. Sorensen’s stage I, as can be seen in table 5, behaves 
erratically. Besides the presence of the extrapolation number the curves for each stage 
show singular slopes. The difference in slope between stages I and II, if it exists at all, 
is small but it is clear that the early and late stages are differentiated by widely different 
slopes. The data of Table 7 follow the exponential regression lines very well when 
the proportion of patients dead by the 5th yr is assumed to be equivalent to the 
expected proportion dead according to our curves. 
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FIG. 2. Survival of patients destined to die of cancer. Stages I and IV. 
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FIG. 3. Survival of patients destined to die of cancer. Stages II and III. 
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DISCUSSION 
We have shown that each clinical stage of carcinoma of the cervix uteri has a 
singular trend of mortality and that the form of the trend is independent of 5 yr 
survival rates. We have defined each stage in terms of an exponential function and 
we have found evidence of the medical literature that supports the view that the 
trends as described have validity beyond the experience of the University of Michigan. 
We have noted a similarity between the survival of failures of treatment and the 
cell survival curves of radiobiology. We may postulate that tumors have to grow 
along the axis of time until they reach such size after which death becomes exponen- 
tial [9]. The extrapolation number is greatest in stage I and reaches unity in stage IV. 
Another feature of interest is that the slope for the survival of doomed cases is 
greatest for the advanced cases and less steep for earlier ones. Myers et al [lo] have 
shown that in carcinoma of the breast the mortality is exponential but when cases 
are grouped according to the presence and absence of favorable prognostic signs the 
slope of the line of regression varies. The slope is steeper in the groups containing 
more unfavorable prognostic signs. 
Another observation of interest is that cases of carcinoma of the cervix that are 
not cured are not grossly affected by treatment. Despite great improvements in the 
5-yr survival rate the sequence of death has not shown major change. This finding 
though upsetting to the intuition cannot be overlooked. A more successful treatment 
does not thereby imply greater palliation in unsuccessful cases, for we have observed 
trends of mortality that are steady for each stage despite variation in the 5-yr survival 
rate. 
Boag has shown that the distribution of the logarithm of survival of treatment 
failures is normal. His observation has been confirmed by others [3, 111. Berg upon 
critically reviewing the validity of the lognormal model concluded that often the 
fitting of models to data is poor particularly in the early post-treatment period. He 
mentions that the exponential model shows considerable deviation from the actuality 
of mortality. We have pointed out earlier that no simple exponential will fit the data 
when the curve is displaced towards the right (when the curve has a shoulder). The 
extrapolation number together with variations in slope are characteristics of the 
stages of carcinoma of the cervix uteri. Upon the framework of exponential attrition 
of the non-cured population other attrition forces superimpose themselves on the 
remaining cured population [13]. The result is a general survival curve of greater 
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